🔬 Science
7h ago
Evaluating effectiveness of maternal RSV vaccination and nirsevimab for severe RSV-related illness in infants
Source ↗
👁 0
💬 0
A new study found that infants receiving maternal Respiratory Syncytial Virus (RSV) vaccination or Nirsevimab after birth had significantly lower RSV infection and health care use compared to unprotected infants. It also showed fewer severe complications in RSV-positive infants with prevention. These findings highlight the positive impact of RSV preventive measures in high-risk populations. Findings from the study will be presented at the Pediatric Academic Societies (PAS) 2026 Meeting, taking p
Comments (0)